LEES PHARMACEUTICAL HLDGS

The current price of 950 is 1.09 HKD — it has decreased by 5.22% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange LEES PHARMACEUTICAL HLDGS stocks are traded under the ticker 950.

LEES PHARMACEUTICAL HLDGS is going to release the next earnings report on Aug 29, 2024. Keep track of upcoming events with our Earnings Calendar.

950 stock is 5.50% volatile and has beta coefficient of 0.46. Check out the list of the most volatile stocks — is LEES PHARMACEUTICAL HLDGS there?

Yes, you can track LEES PHARMACEUTICAL HLDGS financials in yearly and quarterly reports right on TradingView.

950 stock has fallen by 3.54% compared to the previous week, the month change is a 10.66% fall, over the last year LEES PHARMACEUTICAL HLDGS has showed a 22.14% decrease.

LEES PHARMACEUTICAL HLDGS dividend yield was 1.18% in 2023, and payout ratio reached 63.38%. The year before the numbers were 1.23% and 22.96% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.

Like other stocks, 950 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LEES PHARMACEUTICAL HLDGS stock right from TradingView charts — choose your broker and connect to your account.

950 reached its all-time high on May 26, 2015 with the price of 15.40 HKD, and its all-time low was 1.12 HKD and was reached on Apr 10, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 26, 2024, the company has ‪1.06 K‬ employees. See our rating of the largest employees — is LEES PHARMACEUTICAL HLDGS on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LEES PHARMACEUTICAL HLDGS technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LEES PHARMACEUTICAL HLDGS stock shows the sell signal. See more of LEES PHARMACEUTICAL HLDGS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on LEES PHARMACEUTICAL HLDGS future price: according to them, 950 price has a max estimate of 1.00 HKD and a min estimate of 1.00 HKD. Read a more detailed LEES PHARMACEUTICAL HLDGS forecast: see what analysts think of LEES PHARMACEUTICAL HLDGS and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LEES PHARMACEUTICAL HLDGS EBITDA is ‪109.82 M‬ HKD, and current EBITDA margin is 10.43%. See more stats in LEES PHARMACEUTICAL HLDGS financial statements.